ERA BIOLOGY Great Show at Africa Health 2022
Gallagher Convention Center, Johannesburg, South Africa – 26th-28th October – ERA BIOLOGY participated in Africa Health 2022, which is the most influent...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...
The 32nd European Congress of Clinical Microbiology and Infectious Diseases, which will take place for the first time as a hybrid event both online and on-site in Lisbon.
Era Biology will offer fu...
On May 19th, Era Biology host the global live webinar. The webinar talks about three different solutions using fungus (1-3)-β-D Glucan Test to achieve early and rapid diagnosis of invasive fungal d...
Meet Era Biology at Medlab Middle East 2023
The Medlab Middle East 2023 exhibition will be held in Dubai World Trade Centre, The United Arab Emirates on 6-9 February 2023.
As the largest healthcare...
YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...